Current topics on centrifugal plasmapheresis technologies.
In the field of plasmapheresis centrifugal technology has recently focused on the collection of peripheral blood stem cells (PBSCs) for both autologous and allogeneic transplantation in patients with malignancies or hematological diseases and on donor plasmapheresis. PBSC transplantation is rapidly replacing bone marrow transplantation in such patients. Various kinds of apheresis equipment were applied and described for PBSC collection. Comparison among machines is described. Allogeneic PBSCs were collected from healthy normal donors. Specific attention to the dose and administration duration of granulocyte colony-stimulating factor and a careful apheresis procedure should be made for donor safety. In platelet transfusion practice, a platelet concentrate product derived plateletpheresis from a single donor is preferable to minimize and to prevent adverse transfusion reactions. The status of platelet collection and its efficacy by various kinds of plateletpheresis equipment are discussed. The Amicus and CCS might be preferable plateletpheresis machines because of their collection efficiencies and wider indication for donors. With the limited number of donors, it is essential that plateletpheresis should be more effectively performed and managed by each regional blood center. The status of plasma and red cell collection by apheresis technologies is described also briefly.
Omokawa
S
S
Division of Transfusion Medicine, Akita University School of Medicine, Japan. somokawa@hos.akita-u.ac.jp
D002498:Centrifugation; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D010956:Plasmapheresis / Q000379:methods